Q1 EPS Estimates for Astera Labs Lifted by Northland Capmk

Astera Labs, Inc. (NASDAQ:ALAB) – Stock analysts at Northland Capmk increased their Q1 2025 earnings per share estimates for Astera Labs in a research report issued on Tuesday, February 11th. Northland Capmk analyst G. Richard now anticipates that the company will post earnings per share of $0.06 for the quarter, up from their previous forecast of ($0.01). Northland Capmk has a “Strong-Buy” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs’ Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.07 EPS, FY2025 earnings at $0.25 EPS and FY2026 earnings at $0.61 EPS.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%.

Several other research firms have also issued reports on ALAB. Craig Hallum increased their price objective on Astera Labs from $105.00 to $125.00 and gave the stock a “buy” rating in a research note on Tuesday. Morgan Stanley lowered their target price on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 28th. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Finally, Citigroup began coverage on shares of Astera Labs in a research note on Monday, November 18th. They set a “buy” rating and a $120.00 price target on the stock. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $115.33.

Astera Labs Price Performance

Shares of ALAB opened at $88.19 on Friday. Astera Labs has a 1 year low of $36.22 and a 1 year high of $147.39. The stock has a 50 day simple moving average of $121.35 and a 200-day simple moving average of $82.90.

Insider Buying and Selling at Astera Labs

In related news, General Counsel Philip Mazzara sold 2,513 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.81, for a total transaction of $228,205.53. Following the completion of the transaction, the general counsel now owns 248,745 shares in the company, valued at approximately $22,588,533.45. The trade was a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stefan A. Dyckerhoff sold 197,297 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the completion of the sale, the director now directly owns 6,148 shares of the company’s stock, valued at $556,455.48. The trade was a 96.98 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 846,452 shares of company stock worth $86,427,256.

Hedge Funds Weigh In On Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in the company. MML Investors Services LLC acquired a new position in Astera Labs in the fourth quarter valued at about $1,401,000. MetLife Investment Management LLC raised its holdings in Astera Labs by 391.3% during the 4th quarter. MetLife Investment Management LLC now owns 2,137 shares of the company’s stock worth $283,000 after buying an additional 1,702 shares during the period. Natixis bought a new position in Astera Labs in the fourth quarter valued at approximately $15,755,000. Dimensional Fund Advisors LP boosted its holdings in shares of Astera Labs by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 18,250 shares of the company’s stock valued at $2,417,000 after buying an additional 768 shares during the period. Finally, First Trust Advisors LP increased its position in shares of Astera Labs by 78.3% during the fourth quarter. First Trust Advisors LP now owns 123,901 shares of the company’s stock worth $16,411,000 after acquiring an additional 54,413 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.